Miromatrix Medical Inc. financial data

Symbol
MIRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6455 Flying Cloud Drive, Suite 107, Eden Prairie, Minnesota
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q3 2023 - Nov 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 547 % -51.7%
Debt-to-equity 32.8 % +98.7%
Return On Equity -120 % -84.3%
Return On Assets -90.7 % -61.7%
Operating Margin -2.99 K % +96.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.4 M shares +31.2%
Common Stock, Shares, Outstanding 27.4 M shares +31.2%
Entity Public Float 73.5 M USD -64.8%
Common Stock, Value, Issued 274 USD +31.1%
Weighted Average Number of Shares Outstanding, Basic 27.3 M shares +30.7%
Weighted Average Number of Shares Outstanding, Diluted 27.3 M shares +30.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 958 K USD +2979%
Research and Development Expense 16.3 M USD -2.25%
Operating Income (Loss) -28.6 M USD +0.16%
Nonoperating Income (Expense) 181 K USD +41.5%
Net Income (Loss) Attributable to Parent -27.4 M USD +3.79%
Earnings Per Share, Basic -1.14 USD/shares -65.2%
Earnings Per Share, Diluted -1.14 USD/shares -65.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.12 M USD +10.4%
Accounts Receivable, after Allowance for Credit Loss, Current 11.2 K USD
Assets, Current 17.2 M USD -47.6%
Property, Plant and Equipment, Net 4.71 M USD -19%
Operating Lease, Right-of-Use Asset 1.52 M USD -11.9%
Assets 23.4 M USD -42.3%
Accounts Payable, Current 1.05 M USD -9.44%
Accrued Liabilities, Current 2.62 M USD +64.8%
Liabilities, Current 4.97 M USD +22.4%
Operating Lease, Liability, Noncurrent 2.41 M USD -14.7%
Liabilities 7.88 M USD +0.18%
Retained Earnings (Accumulated Deficit) -124 M USD -28.2%
Stockholders' Equity Attributable to Parent 15.5 M USD -52.5%
Liabilities and Equity 23.4 M USD -42.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.62 M USD -16%
Net Cash Provided by (Used in) Financing Activities 9.04 M USD
Net Cash Provided by (Used in) Investing Activities 7.98 M USD
Common Stock, Shares Authorized 190 M shares 0%
Common Stock, Shares, Issued 27.4 M shares +31.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.92 M USD +9.12%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.17 K USD -24.8%
Deferred Tax Assets, Valuation Allowance 34.6 M USD +163%
Deferred Tax Assets, Gross 34.9 M USD +166%
Operating Lease, Liability 2.82 M USD -11.9%
Lessee, Operating Lease, Liability, to be Paid 3.18 M USD -13.8%
Property, Plant and Equipment, Gross 7.43 M USD +0.72%
Operating Lease, Liability, Current 414 K USD +8.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 543 K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 527 K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 361 K USD -25.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 559 K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 10.1 M USD +45.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 576 K USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.16 M USD +29.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%